Acacia Research insider plans sale of 32,188 shares

Acacia Research Corporation (ACTG) has a notice from an affiliate indicating an intention to sell up to 32,188 shares of common stock, with an aggregate market value of $150,199.00, on or after August 12, 2026 on the Nasdaq Global Select Market.

Rhea-AI Filing Summary

Acacia Research Corporation (ACTG) has a notice from an affiliate indicating an intention to sell up to 32,188 shares of common stock, with an aggregate market value of $150,199.00, on or after August 12, 2026 on the Nasdaq Global Select Market.

The filing also lists prior issuances of restricted stock by the issuer for services rendered, including 30,534 shares granted on May 26, 2023 and 32,172 shares granted on May 30, 2025.

Key Figures

Planned shares to be sold: 32,188 shares Aggregate market value: $150,199.00 Restricted stock grant: 30,534 shares +2 more

5 metrics

Planned shares to be sold 32,188 shares Common stock planned for sale on or after August 12, 2026

Aggregate market value $150,199.00 Aggregate market value of the 32,188 shares planned for sale

Restricted stock grant 30,534 shares Issuer grant of restricted stock on May 26, 2023 for services rendered

Restricted stock grant 32,172 shares Issuer grant of restricted stock on May 30, 2025 for services rendered

Planned sale date 08/12/2026 Earliest date for proposed sale of 32,188 common shares

Key Terms

Form 144, restricted stock, Nasdaq Global Select

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock financial

"Grant of restricted stock | Issuer | | | 30534 | 05/26/2023"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Nasdaq Global Select market

"08/12/2026 | Nasdaq Global Select 144: Securities To Be Sold"

A Nasdaq Global Select listing is the highest-quality tier on the Nasdaq stock exchange, awarded to companies that meet the strictest financial, reporting and governance standards. Think of it as a “premium shelf” in a store: it signals stronger oversight, transparency and liquidity compared with lower tiers, which helps investors judge company reliability, compare risk, and may attract more institutional buyers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ACTG Form 144 filing disclose about planned stock sales?

The filing discloses an intention to sell up to 32,188 shares of Acacia Research common stock with an aggregate market value of $150,199.00, expected to be sold on or after August 12, 2026 on the Nasdaq Global Select Market.

How many ACTG shares are covered by the planned sale in this Form 144?

The planned sale covers up to 32,188 shares of Acacia Research common stock. The filing associates these shares with an aggregate market value of $150,199.00 for potential sales on or after August 12, 2026.

What prior restricted stock grants are referenced for ACTG in this Form 144?

The filing references issuer grants of restricted stock for services rendered: 30,534 shares granted on May 26, 2023 and 32,172 shares granted on May 30, 2025, both in Acacia Research common stock.

On which market are the ACTG shares in this Form 144 expected to be sold?

The shares are expected to be sold on the Nasdaq Global Select Market. The filing lists Acacia Research common stock, with up to 32,188 shares planned for sale beginning on or after August 12, 2026.

Who is associated with the ACTG shares listed in this Form 144?

The shares are associated with Roy Tedeschi and Schmidt Private Wealth & Partners, which are identified in connection with the 32,188 Acacia Research common shares planned for potential sale under this Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 03:17 PM Accepted by SEC EDGAR 08/12/2026 - 03:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001776505
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ACACIA RESEARCH CORP
SEC File Number	001-37721
Address of Issuer	777 3RD AVENUE SUITE 2602 NEW YORK NEW YORK 10017
Phone	332-236-8500
Name of Person for Whose Account the Securities are To Be Sold	Kohlberg Isaac T.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Roy | Tedeschi | Schmidt Private Wealth &Partners 280 Summer Street 9th Floor Boston MA 02210	32188	150199.00	97586806	08/12/2026	Nasdaq Global Select

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/26/2023	Grant of restricted stock	Issuer			30534	05/26/2023	Services rendered
Common Stock	05/30/2025	Grant of restricted stock	Issuer			32172	05/30/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Graff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)